The United Kingdom Prospective Diabetes Study (UKPDS) showed that intensive
treatment (ie, glucose-lowering drugs, with a goal fasting blood glucose l
evel of 108 mg/dL) decreases the microvascular complications of type 2 diab
etes mellitus. We summarize the key study results and their implications fo
r clinical management of type 2 diabetes mellitus.